Determination of intracellular reduced glutathione and glutathione related enzyme activities in cisplatin-sensitive and resistant experimental ovarian carcinoma cell lines
- PMID: 2766260
- DOI: 10.1016/0304-3835(89)90132-8
Determination of intracellular reduced glutathione and glutathione related enzyme activities in cisplatin-sensitive and resistant experimental ovarian carcinoma cell lines
Abstract
The level of GSH in ovarian carcinoma cells which were sensitive and resistant to cisplatin was serially determined following tumor removal from the animals, in addition, activities of GSH-reductase and GSH-S-transferase were assessed. The GSH level in the resistant line (O-342/DDP) was almost twice as high as that in its sensitive counterpart (O-342), when determined immediately following removal of the tumor (1.55 +/- 0.47 vs. 0.81 +/- 0.32 nmol/10(6) cells). Culturing the cells resulted in a decrease of GSH levels in both cell lines during the first 4 h. Thereafter, GSH levels in both cell lines increased up to 24 h. At this time the GSH level was higher in O-342 than in O-342/DDP. GSH-reductase activity in O-342/DDP cells was significantly higher than in O-342 cells when the enzyme was determined immediately after tumor removal; at the same time there was no difference in activity of GSH-S-transferase between two cell lines. After 24 h in culture, no significant difference between O-342 and O-342/DDP cells could be observed in the activity of the two enzymes.
Similar articles
-
Chemoresistance in rat ovarian tumours.Eur J Cancer. 1991;27(1):62-7. doi: 10.1016/0277-5379(91)90063-j. Eur J Cancer. 1991. PMID: 1826445
-
Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells.Cancer Res. 1995 Oct 1;55(19):4297-301. Cancer Res. 1995. PMID: 7671239
-
Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.Cancer. 1996 May 1;77(9):1797-808. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1797::AID-CNCR7>3.0.CO;2-9. Cancer. 1996. PMID: 8646677
-
Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.Cancer Res. 1991 Oct 1;51(19):5181-7. Cancer Res. 1991. PMID: 1717140
-
Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells.Free Radic Res. 1999 Dec;31(6):549-58. doi: 10.1080/10715769900301121. Free Radic Res. 1999. PMID: 10630679
Cited by
-
Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines.Br J Cancer. 1997;75(3):333-40. doi: 10.1038/bjc.1997.55. Br J Cancer. 1997. PMID: 9020476 Free PMC article.
-
In vitro evaluation of platinum, titanium and ruthenium metal complexes in cisplatin-sensitive and -resistant rat ovarian tumors.Cancer Chemother Pharmacol. 1991;27(4):301-7. doi: 10.1007/BF00685116. Cancer Chemother Pharmacol. 1991. PMID: 1998986
-
In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell line.J Cancer Res Clin Oncol. 1990;116(5):443-7. doi: 10.1007/BF01612991. J Cancer Res Clin Oncol. 1990. PMID: 2121738 Free PMC article.
-
Identification of chemoresistant factors by protein expression analysis with iTRAQ for head and neck carcinoma.Br J Cancer. 2014 Aug 12;111(4):799-806. doi: 10.1038/bjc.2014.395. Epub 2014 Jul 17. Br J Cancer. 2014. PMID: 25032734 Free PMC article.
-
Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum.Mol Cell Biochem. 2001 Mar;219(1-2):51-6. doi: 10.1023/a:1011083429704. Mol Cell Biochem. 2001. PMID: 11354253
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical